COPD Drug Development: Advancing New Therapies for Chronic Obstructive Pulmonary Disease

COPD Drug Development: Advancing New Therapies for Chronic Obstructive Pulmonary Disease

by Virtus | Jun 28, 2026 | Early-Stage Respiratory Drug Development

COPD drug development is one of the most active areas of respiratory research as scientists work to develop new therapies for chronic obstructive pulmonary disease. COPD affects hundreds of millions of people worldwide and remains a leading cause of illness and...
Asthma Drug Development: Advancing New Treatments for Respiratory Disease

Asthma Drug Development: Advancing New Treatments for Respiratory Disease

by Virtus | Jun 6, 2026 | Early-Stage Respiratory Drug Development

Asthma drug development plays a critical role in improving outcomes for millions of people living with asthma worldwide. Despite significant advances in treatment, asthma remains a complex and highly variable respiratory disease that continues to drive demand for...
Respiratory Disease Models: Understanding the Foundation of Preclinical Respiratory Research

Respiratory Disease Models: Understanding the Foundation of Preclinical Respiratory Research

by Virtus | Jun 6, 2026 | Respiratory Preclinical Research

Respiratory disease models are essential tools in preclinical respiratory research, allowing scientists to investigate disease mechanisms, evaluate therapeutic candidates and generate data that supports respiratory drug development. From asthma and COPD to viral...
COPD Drug Development: Advancing New Therapies for Chronic Obstructive Pulmonary Disease

Respiratory Drug Development: From Discovery to Clinical Trials

by Virtus | Jun 6, 2026 | Early-Stage Respiratory Drug Development

Respiratory drug development is a complex process that transforms scientific discoveries into therapies for patients with respiratory diseases. From asthma and COPD to viral respiratory infections, developing new respiratory medicines requires a combination of...
Preclinical Respiratory Models: A Guide to Asthma, COPD and Viral Disease Research

Preclinical Respiratory Models: A Guide to Asthma, COPD and Viral Disease Research

by Virtus | Jun 6, 2026 | Respiratory Preclinical Research

Preclinical respiratory models play a vital role in respiratory drug development by allowing researchers to evaluate therapeutic candidates before clinical trials begin. These models are used throughout respiratory preclinical research to investigate disease...
« Older Entries
Next Entries »

Recent Posts

  • Preclinical COPD Models: Choosing the Right Approach for Drug Development
  • Bronchoalveolar Lavage in Preclinical Respiratory Research
  • In Vitro Respiratory Disease Models: Applications in Preclinical Drug Discovery
  • Preclinical Respiratory Efficacy Studies: Choosing the Right Models, Endpoints and Research Approach
  • Airway Hyperresponsiveness Models in Preclinical Asthma Research

Recent Comments

No comments to show.

Privacy Notice and Cookie Policy





All content © 2022 Virtus Respiratory Research. All Rights Reserved.

Contact